PD-1 blockade after PD-(L)1 inhibitors in head and neck cancer: Role of immunotherapy rechallenge.

Cabezas-Camarero, S; Perez-Segura, P

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (8):